Who we are

Managed by Brandon Capital, Brandon BioCatalyst supports the development and commercialisation of early-stage biomedical discoveries originating from member research organisations, providing both capital and expertise to guide the successful development of new therapies.

Brandon BioCatalyst is a unique collaboration of investors, CSL, government and more than 50 leading medical research institutes and hospitals united by a single purpose: generating cutting edge, next generation medical therapies and technologies to improve health and save lives.

    Technologies, expertise

    50+ Medical research institutes and hospitals

    Operational support

    ACT Government
    NSW Government Health
    Government of South Australia
    Queensland Government
    Victorian Government
    Western Australian Government
    Ministry of Business, Innovation & Employment (MBIE) NZ

    Management

    Brandon Capital

    Independent Governance
    Investors

    Australian Government
    Australian Super
    Hesta
    Host Plus
    TelstraSuper
    CSL

Members

Institute
The Walter and Eliza Hall Institute of Medicinal Research

The Walter and Eliza Hall Institute is the oldest medical research institute in Australia and will celebrate its centenary in 2015.

The institute is affiliated with The University of Melbourne and The Royal Melbourne Hospital and offers postgraduate training as the Department of Medical Biology of The University of Melbourne.

View
Institute
St Vincent’s Institute of Medical Research

SVI is an independent medical research institute that conducts research into the cause, prevention and treatment of diseases that are common and have serious effects on health. We strive, through our research, to help alleviate the enormous financial, emotional and physical impacts of these diseases on individuals, their families and the community.

View
Institute
Alfred Health

Alfred Health is a leader in health care delivery, improvement, research and education. It strives to achieve best possible health outcomes for patients and the community by integrating clinical practice with research and education.

View

Government Partners

Investors

Brandon BioCatalyst's investors are AustralianSuper, HESTA, HOSTPLUS, TelstraSuper, CSL and the Australian Government under its IIF and BTF programs.

Brandon Capital

Brandon Capital manages Brandon BioCatalyst, providing seed and venture capital investment to support the development and international growth of Australian and New Zealand life science companies.

Brandon Capital website